Log in to search using one of your social media accounts:

 

Often, Opioid Abuse Becomes a Family Affair
If someone is taking prescription opioids for pain, such as OxyContin, it's more likely that others living in the home will also get an opioid prescription, the researchers found. (Source: WebMD Health)
Source: WebMD Health - December 11, 2017 Category: Consumer Health News Source Type: news

Often, Opioid Abuse Becomes a Family Affair
MONDAY, Dec. 11, 2017 -- Opioid addiction often starts in the family medicine cabinet, a new study warns. If someone is taking prescription opioids for pain, such as OxyContin, it's more likely that others living in the home will also get an opioid... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 11, 2017 Category: General Medicine Source Type: news

An Illinois doctor traded drugs for sex and cash. He just pleaded guilty.
The first scheme that Constantino Perales ran involved some simple math. He'd provide a drug dealer with hundreds of oxycodone and Xanax pills and the man would pay the doctor $15 to $20 for every tablet he sold, according to federal prosecutors. The second scheme was even simpler, if baser. Perales would write prescriptions for the drugs; […]Related:The moral differences between pro- and anti-vaccine parents‘The Woebot will see you now’ — the rise of chatbot therapyA woman with a transplanted uterus just gave birth — a first for the U.S. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - December 5, 2017 Category: Consumer Health News Source Type: news

Montana sues OxyContin maker Purdue over opioid epidemic
(Reuters) - Montana has sued OxyContin maker Purdue Pharma LP, withdrawing from a multistate investigation by attorneys general into opioid manufacturers' marketing practices and joining a growing list of states that have broken off to pursue individual lawsuits. (Source: Reuters: Health)
Source: Reuters: Health - December 4, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Approves Monthly Injection for Opioid Addiction Treatment
WASHINGTON (AP) — U.S. health officials on Thursday approved the first injectable form of the leading medication to treat patients recovering from addiction to heroin, prescription painkillers and other opioids. The Food and Drug Administration approved once-a-month Sublocade for adults with opioid use disorder who are already stabilized on addiction medication. The monthly injection has the potential to reduce dangerous relapses that occur when patients stop taking the currently available daily medication. But that benefit has not yet been shown in studies and the new drug comes with a hefty price: $1,580 per monthl...
Source: JEMS Patient Care - December 1, 2017 Category: Emergency Medicine Authors: Matthew Perrone, Associated Press Tags: Patient Care News Source Type: news

FDA Approves Monthly Injection for Opioid Addiction Treatment
WASHINGTON (AP) — U.S. health officials on Thursday approved the first injectable form of the leading medication to treat patients recovering from addiction to heroin, prescription painkillers and other opioids. The Food and Drug Administration approved once-a-month Sublocade for adults with opioid use disorder who are already stabilized on addiction medication. The monthly injection has the potential to reduce dangerous relapses that occur when patients stop taking the currently available daily medication. But that benefit has not yet been shown in studies and the new drug comes with a hefty price: $1,580 per monthl...
Source: JEMS: Journal of Emergency Medical Services News - December 1, 2017 Category: Emergency Medicine Authors: Matthew Perrone, Associated Press Tags: Patient Care News Source Type: news

Another Opioid Scourge: Dangerous Infections
ERs are seeing an increasing number of patients seeking care for severe infections resulting from injected use of heroin, fentanyl, oxycodone and the like, new research shows. (Source: WebMD Health)
Source: WebMD Health - November 30, 2017 Category: Consumer Health News Source Type: news

Egalet ’ s extended-release, abuse-deterrent opioid succeeds in Ph3 trial
Shares in Egalet Corp. (NSDQ:EGLT) soared this morning in pre-market activity after the company reported that its abuse-deterrent, extended-release oxycodone candidate met the primary endpoint of a Phase III pain relief trial. The Wayne, Penn.-based company compared the efficacy and safety of its product to a placebo in opioid-experienced and opioid-naïve patients with moderate-to-severe chronic low back pain. Get the full story at our sister site, Drug Delivery Business News. The post Egalet’s extended-release, abuse-deterrent opioid succeeds in Ph3 trial appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 28, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Pain Management Pharmaceuticals Wall Street Beat egalet Source Type: news

Are ibuprofen plus acetaminophen as good as opioids in treating acute extremity pain
3.5 out of 5 stars Effect of a Single Dose of Oral Opioid and Nonopioid Analgesics on Acute Extremity Pain in the Emergency Department: A Randomized Clinical Trial. Chang AK et al. JAMA 2017;318:1661-1667. Abstract As Dr. Demetrios Kyriacou points out in a must-read editorial accompanying this paper, a growing body of evidence clearly indicates that even short-term opioid use for painful injuries or procedures carries a significant risk of leading to chronic use and potential abuse. We are now realizing the importance of avoiding even limited use of drugs such as oxycodone and hydrocodone in opioid-naive patients...
Source: The Poison Review - November 22, 2017 Category: Toxicology Authors: Leon Gussow Tags: Medical acute pain analgesic emergency department opioid Source Type: news

Digital pills successfully monitor opioid use after injury
(Brigham and Women's Hospital) BWH investigators report on the results from a pilot study of 15 individuals who received a prescription to take oxycodone digital pills as needed following treatment for acute fractures. The team found that the opioid-na ï ve patients self-administered opioids to manage pain for only a brief period and only took a fraction of the number of pills they were given. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 20, 2017 Category: International Medicine & Public Health Source Type: news

Study Reveals Possible Connection Between High Fructose Corn Syrup And Opioid Addiction
New research shows an interesting interplay between high fructose corn syrup and oxycodone in the brains of rats, with revealing insights for humans taking opioids. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 16, 2017 Category: Pharmaceuticals Authors: David DiSalvo, Contributor Source Type: news

Kratom Herbal Supplement Can Lead To Addiction, Death Says FDA
WASHINGTON (AP) — Federal health authorities are warning about reports of injury, addiction and death with a herbal supplement that has been promoted as an alternative to opioid painkillers and other prescription drugs. The supplement, kratom, made from a plant native to Southeast Asia, has gained popularity in the U.S. as a treatment for pain, anxiety and drug dependence. Users have opposed efforts to regulate the plant, saying it could be a safer alternative to opioid pain pills that have caused an epidemic of abuse. But the Food and Drug Administration said Tuesday that kratom carries similar risks, including addi...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 14, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News FDA Kratom Source Type: news

Alternatives to Opioids for Pain Relief
A combination of Tylenol and Advil worked just as well as opioids for relief of pain in the emergency room, a randomized trial has found. (Source: NYT Health)
Source: NYT Health - November 8, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Pain-Relieving Drugs Tylenol (Drug) Emergency Medical Treatment OxyContin (Drug) Codeine Ibuprofen (Drug) Source Type: news

Florida Blue to stop covering controversial opiates
Jacksonville-based Florida Blue, the leading health insurer in Florida, has announced that it will no longer cover OxyContin starting Jan. 1, 2018 in its commercial insurance lines. The move is in response to a nationwide opioid epidemic. President Donald Trump declared a National Public Health Emergency regarding the opioid epidemic in October, and Gov. Rick Scott has signed an executive order proclaiming the issue a "statewide emergency." Florida Blue has made the move b ecause the drug is easier… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 8, 2017 Category: Health Management Authors: Derek Gilliam Source Type: news

Florida Blue to stop covering controversial opiates
Florida Blue, the leading health insurer in Florida, no longer will cover OxyContin starting Jan. 1 in its commercial insurance lines. The move is in response to a nationwide opioid epidemic. President Donald Trump declared a National Public Health Emergency regarding the opioid epidemic in October, and Gov. Rick Scott has signed an executive order proclaiming the issue a statewide emergency. Florida Blue has made the move bec ause the drug is easier to abuse through crushing the pills, according… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 8, 2017 Category: Pharmaceuticals Authors: Derek Gilliam Source Type: news

Meet Portland's top opioid prescriber
Dr. Stuart Rosenblum, who is board-certified  in pain medicine and anesthesia, is the top prescriber of the opioid painkiller oxycodone in Portland and the fifth-highest in the state, according to a list compiled by ProPublica based on Medicare data. His name also appeared in a document filed by the Oregon Department of Justice in its $1.1 m illion settlement against Insys Therapeutics Inc., a Chandler, Arizona, opioid manufacturer. In detailing Insys’ practices, the Oregon DOJ cited its relationship… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 7, 2017 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

Florida Blue to stop covering controversial opiates
Jacksonville-based Florida Blue, the leading health insurer in Florida, has announced that it will no longer cover OxyContin starting Jan. 1, 2018 in its commercial insurance lines. The move is in response to a nationwide opioid epidemic. President Donald Trump declared a National Public Health Emergency regarding the opioid epidemic in October, and Gov. Rick Scott has signed an executive order proclaiming the issue a "statewide emergency." Florida Blue has made the move b ecause the drug is easier… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 7, 2017 Category: Pharmaceuticals Authors: Derek Gilliam Source Type: news

Over-The-Counter Pain Relievers Worked As Well As Opioids In New Study
CHICAGO (AP) — Emergency rooms are where many patients are first introduced to powerful opioid painkillers, but what if doctors offered over-the-counter pills instead? A new study tested that approach on patients with broken bones and sprains and found pain relievers sold as Tylenol and Motrin worked as well as opioids at reducing severe pain. The results challenge common ER practice for treating short-term, severe pain and could prompt changes that would help prevent new patients from becoming addicted. The study has limitations: It only looked at short-term pain relief in the emergency room and researchers didn&rsq...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 7, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Confronting The Crisis opioid crisis Source Type: news

New Jersey Sues OxyContin Maker, Links Marketing To Opioid Crisis
The state’s attorney general accused the company of downplaying the risks and exaggerating the benefits of opioids in the pursuit of profit. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - November 2, 2017 Category: Consumer Health News Source Type: news

Ohio AG gives McKesson, others 30 days to be 'part of the solution' on addictive opioids
Ohio's attorney general fired off letters to the CEOs of five makers of pain-killing opioid drugs and the leaders of other healthcare companies, including San Francisco-based wholesaler McKesson Corp., to force accountability for the state's opioid epidemic. Attorney General Mike DeWine's letters Monday aren't the first moves aimed at rolling back addiction to opioids, a class of drugs that includes prescription painkillers, such as oxycodone, and the street-level drugs heroin and fentanyl. Various… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 1, 2017 Category: Health Management Authors: Ron Leuty Source Type: news

Ohio AG gives McKesson, others 30 days to be 'part of the solution' on addictive opioids
Ohio's attorney general fired off letters to the CEOs of five makers of pain-killing opioid drugs and the leaders of other healthcare companies, including San Francisco-based wholesaler McKesson Corp., to force accountability for the state's opioid epidemic. Attorney General Mike DeWine's letters Monday aren't the first moves aimed at rolling back addiction to opioids, a class of drugs that includes prescription painkillers, such as oxycodone, and the street-level drugs heroin and fentanyl. Various… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 1, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news

New Jersey becomes latest state to sue Purdue Pharma over OxyContin
State attorney general points 'finger of blame' at Purdue for the opioid epidemic he says has killed thousands in New Jersey. (Source: CBC | Health)
Source: CBC | Health - October 31, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

New Jersey sues OxyContin maker, links marketing to opioid crisis
(Reuters) - New Jersey on Tuesday sued Purdue Pharma LP, maker of the chronic pain medication OxyContin, accusing the company of engaging in deceptive marketing practices that contributed to what it called the state's opioid crisis. (Source: Reuters: Health)
Source: Reuters: Health - October 31, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

NJ sues OxyContin maker, links marketing to opioid crisis
(Reuters) - New Jersey on Tuesday sued Purdue Pharma LP, maker of the chronic pain medication OxyContin, accusing the company of engaging in deceptive marketing practices that contributed to what it called the state's opioid crisis. (Source: Reuters: Health)
Source: Reuters: Health - October 31, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

October 27, 2017: Central Kentucky Pharmacist Sentenced for Conspiracy to Distribute Oxycodone and Money Laundering
(Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - October 30, 2017 Category: Medical Law Source Type: news

Opioid drugmaker Purdue Pharma faces U.S. investigation
(Reuters) - Purdue Pharma LP confirmed on Wednesday that it has become the subject of a U.S. investigation related to its painkiller OxyContin as the drugmaker battles a series lawsuits seeking to hold it responsible for its role in the nation's opioid epidemic. (Source: Reuters: Health)
Source: Reuters: Health - October 25, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Keller @ Large: Rep. Stephen Lynch ‘ Stunned ’ By Opioid Maneuvering In Congress
BOSTON (CBS) – Rep. Stephen Lynch (D-8th District) says he was “stunned” by the March 2016 maneuvering by GOP leaders in Congress to pass a bill curbing federal power to crackdown on suspected opioid distribution scofflaw. “It never came up for a roll call vote,” Lynch said. Instead, as a 60 Minutes/Washington Post expose has documented, the bill breezed through both branches by unanimous consent – no debate or vote – before being signed into law by then-President Obama. “This was treated like the naming of a post office or something like that,” says Lynch in a WBZ-TV i...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 20, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Politics Syndicated Local Jon Keller Keller @ Large opioid crisis Rep Stephen Lynch Source Type: news

Cigna will stop covering OxyContin by 2018
As of January 1, 2018, Cigna, one of the nation's largest health insurers, will instead be covering Xtampza ER, an opioid designed to be difficult to abuse. (Source: the Mail online | Health)
Source: the Mail online | Health - October 10, 2017 Category: Consumer Health News Source Type: news

Teens and opioids: Time for an open conversation
National surveys have found that teens today are much less likely to use alcohol and drugs compared to their parents’ generation. In fact, the proportion of high school seniors who chose not to use alcohol, tobacco, marijuana or other drugs has increased from 3 percent to 25 percent in the last thirty years. This remarkable good news is overshadowed by the growing number of teens who are daily marijuana users and the recent increase in opioid-related deaths among young people. It is important to understand the roots of this discrepancy in order to address it. Statistics show that between 2014 and 2015, the rates of d...
Source: Thrive, Children's Hospital Boston - October 9, 2017 Category: Pediatrics Authors: Nicholas Chadi Tags: Ask the Expert Parenting Teen Health Adolescent Substance Abuse Program Source Type: news

Cigna Says No to OxyContin
Title: Cigna Says No to OxyContinCategory: Health NewsCreated: 10/6/2017 12:00:00 AMLast Editorial Review: 10/9/2017 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - October 9, 2017 Category: Anesthesiology Source Type: news

Cigna Says No to OxyContin
Most OxyContin prescriptions will no longer be covered in Cigna group health plans starting in January, the insurance giant announced. The move is an attempt to help stem the opioid epidemic that has spread across the United States, company... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 6, 2017 Category: General Medicine Source Type: news

Health Highlights: Oct. 6, 2017
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Cigna Says No to OxyContin Most OxyContin prescriptions will no longer be covered in Cigna group health plans starting in January, the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 6, 2017 Category: General Medicine Source Type: news

Cigna to stop covering most OxyContin prescriptions
(Source: CNN.com - Health)
Source: CNN.com - Health - October 5, 2017 Category: Consumer Health News Source Type: news

Will benefit managers jump in with Cigna's move to pull OxyContin?
If Cigna's foray into abuse-deterrent opioids is a success, other payors may follow suit. On Wednesday, Cigna Corp. (NYSE: CI) announced it would no longer cover OxyContin, the opioid painkiller manufactured by Purdue Pharma LP, starting in January. Instead, Cigna will offer Xtampza ER through a "value-based contract" with Collegium Pharmaceutical Inc. While both OxyContin and Xtampza are oxycodone products, Xtampza is supposed to deter drug abuse by remaining an extended-release drug even when… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 5, 2017 Category: American Health Authors: Elise Reuter Source Type: news

Morning Break: Jail Time for Vaccine Refusal; Cigna Nixes OxyContin; PCP Shortage in NYC
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - October 5, 2017 Category: Infectious Diseases Source Type: news

Morning Break: Jail Time for Vaccine Refusal; Cigna Nixes OxyContin; PCP Shortage in Buffalo
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - October 5, 2017 Category: Primary Care Source Type: news

Cigna to end OxyContin painkiller coverage, signs contract for alternative
(Reuters) - Amid a growing U.S. opioid addiction, health insurer Cigna Corp will stop covering OxyContin, the opioid painkiller sold by Purdue Pharma LP, as of Jan. 1 and will instead cover an equivalent with a formulation less vulnerable to abuse, the company said on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - October 4, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

NeuroBreak: FDA Move Shakes Biogen Investors; OxyContin Copy Setback
(MedPage Today) -- News and commentary from the world of neurology and neuroscience (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - October 3, 2017 Category: Primary Care Source Type: news

Cigna Says No to OxyContin
Health insurance giant signs deal with another opioid maker. (Source: WebMD Health)
Source: WebMD Health - October 2, 2017 Category: Consumer Health News Source Type: news

Washington State Sues OxyContin Maker Purdue Pharma Washington State Sues OxyContin Maker Purdue Pharma
Washington state on Thursday sued OxyContin maker Purdue Pharma LP, becoming the latest state or local government to file a lawsuit seeking to hold pharmaceutical companies accountable for a national opioid addiction epidemic.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 29, 2017 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Washington state sues OxyContin maker Purdue Pharma
(Reuters) - Washington state on Thursday sued OxyContin maker Purdue Pharma LP, becoming the latest state or local government to file a lawsuit seeking to hold pharmaceutical companies accountable for a national opioid addiction epidemic. (Source: Reuters: Health)
Source: Reuters: Health - September 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Washington state sues opioid manufacturer Purdue Pharma
(Reuters) - Washington state on Thursday sued OxyContin maker Purdue Pharma LP, becoming the latest state or local government to file a lawsuit seeking to hold pharmaceutical companies accountable for a national opioid addiction epidemic. (Source: Reuters: Health)
Source: Reuters: Health - September 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Opioid overdoses shorten US life expectancy by 2½ months
Opioid drugs -- including both legally prescribed painkillers such as oxycodone and hydrocodone, as well as illegal drugs such as heroin or illicit fentanyl -- are not only killing Americans, but also shortening their overall life spans. Opioids take about 2.5 months off our lives, according to a new analysis published in the medical journal JAMA. (Source: CNN.com - Health)
Source: CNN.com - Health - September 19, 2017 Category: Consumer Health News Source Type: news

Opioid overdoses shorten US life expectancy by 2.5 months
Opioid drugs -- including both legally prescribed painkillers such as oxycodone and hydrocodone, as well as illegal drugs such as heroin or illicit fentanyl -- are not only killing Americans, but also shortening their overall life spans. Opioids take about 2.5 months off our lives, according to a new analysis published in the medical journal JAMA. (Source: CNN.com - Health)
Source: CNN.com - Health - September 19, 2017 Category: Consumer Health News Source Type: news

City asks judge to let case against OxyContin maker proceed
The city of Everett, Washington, is asking a federal judge to let it move forward with a lawsuit against the manufacturer of the prescription opioid painkiller OxyContin (Source: ABC News: Health)
Source: ABC News: Health - September 19, 2017 Category: Consumer Health News Tags: Health Source Type: news

Surgery Can Be Trigger for Teen Opioid Abuse
FRIDAY, Sept. 15, 2017 -- Teens and young adults who have surgery may be at increased risk for opioid painkiller abuse, a new study indicates. Opioids such as oxycodone (OxyContin) and hydrocodone (Vicodin) are commonly prescribed for pain after... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 15, 2017 Category: General Medicine Source Type: news

Do I need Rehab to Quit Oxycontin for Chronic Pain?
Title: Do I need Rehab to Quit Oxycontin for Chronic Pain?Category: Doctor's& Expert's views on SymptomsCreated: 9/15/2017 12:00:00 AMLast Editorial Review: 9/15/2017 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - September 15, 2017 Category: Anesthesiology Source Type: news

Oxycodone vs. Codeine
Title: Oxycodone vs. CodeineCategory: MedicationsCreated: 9/14/2017 12:00:00 AMLast Editorial Review: 9/14/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - September 14, 2017 Category: Drugs & Pharmacology Source Type: news

Dilaudid vs. Oxycodone
Title: Dilaudid vs. OxycodoneCategory: MedicationsCreated: 9/14/2017 12:00:00 AMLast Editorial Review: 9/14/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - September 14, 2017 Category: Drugs & Pharmacology Source Type: news